Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin.
D015250:Aclarubicin; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D003630:Daunorubicin / Q000494:pharmacology*; D004317:Doxorubicin / Q000494:pharmacology*; D004351:Drug Resistance; D009279:Naphthacenes / Q000378:metabolism / Q000494:pharmacology; D009696:Nucleic Acids / Q000096:biosynthesis
D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D009696:Nucleic Acids; D015250:Aclarubicin; D004317:Doxorubicin; D003630:Daunorubicin